It is foreseeable that a new class of antibiotics that target the bacterial SRP through disruption of FtsY interactions will provide a valuable pathway to fighting bacterial infections that are resistant to all currently available drugs. The gene discussed is UCN2; the disease is bacterial infectious disease.